🔎 Trials Near Me

Akèy › ALS ak Maladi Neuròn Motor

Etid klinik pou ALS ak Maladi Neuròn Motor ap rekrite nan Etazini

23 etid pou ALS ak Maladi Neuròn Motor ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

Ap rekriteFaz 1
Laj 18 a 99 · Tout sèks · Mizajou Oct 1, 2026 · NCT07204977

Developing New Ways to Detect Respiratory Impairment Early in ALS

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07844590

Study of Inherited Neurological Disorders

Ap rekriteEtid obsèvasyon
Laj 2 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00004568

Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

Ap rekriteVolontè an sante akeyi
Laj 2 a 110 · Tout sèks · Mizajou Sep 28, 2026 · NCT01900132

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Sep 17, 2026 · NCT03225144

Biofluid Research on Age-Related or Inherited Neurodegeneration

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07798700

Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Gason · Mizajou Aug 13, 2026 · NCT04944940

Healing ALS Registry Observational Study (HAROS)

Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Jun 24, 2026 · NCT07233148

Clinical Procedures to Support Research in ALS

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03489278

A Study of Ranolazine in ALS

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06527222

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT07543367

Non-invasive BCI-controlled Assistive Devices

Ap rekriteVolontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou May 1, 2026 · NCT05183152

The National Amyotrophic Lateral Sclerosis Registry

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT01772602

AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06665165

Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT07491484

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

Ap rekriteEtid obsèvasyon
1 Month – 30 Years · Tout sèks · Mizajou Mar 18, 2026 · NCT05354622

Spastic Paraplegia - Centers of Excellence Research Network

Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Mar 18, 2026 · NCT06553976

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT07478172

Imaging Biomarkers in ALS

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 75 · Tout sèks · Mizajou Dec 2, 2025 · NCT02567136

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05137665

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Ap rekriteFaz 3
Laj 18 a 81 · Tout sèks · Mizajou Sep 12, 2025 · NCT03127267

ALS Research Collaborative

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2025 · NCT06885918

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.